Paloma Partners Management CO Co Diagnostics, Inc. Transaction History

Paloma Partners Management CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.76 - $6.29 $70,849 - $118,522	-18,843 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.03 - $9.61 $94,780 - $181,081	18,843 New	18,843 $116,000
Q4 2020 Feb 16, 2021	SELL	$9.3 - $15.19 $351,781 - $574,576	-37,826 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$8.24 - $30.8 $35,390 - $132,286	-4,295 Reduced 10.2%	37,826 $514,000
Q2 2020 Aug 14, 2020	BUY	$7.46 - $23.42 $139,681 - $438,516	18,724 Added 80.03%	42,121 $815,000
Q1 2020 May 15, 2020	BUY	$0.91 - $17.81 $21,291 - $416,700	23,397 New	23,397 $178,000

4.28M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $27.7M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.